Viatris and Biocon consider merger of their biosimilars into a US$10B standalone company by Editor | Dec 13, 2021 | Hospitals, LATEST NEWS, Mergers, Investments & Funding, WORLD NEWS | 0 INDIA – Viatris and India’s Biocon Biologics are debating whether to further integrate their... Read More